Evidence map›Paper›PMID 41922797›Full record

ArticleGenes and immunity2026

FOLR3+neutrophils contribute to sepsis by exacerbating hyper-inflammation.

Fangchao Chen, Hongyu Tan, Dianyang Wang, Rui Su, Jiaxiang Liao, Hongfei Ge, Wei Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fangchao Chen *Department of Emergency, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.ORCID http://orcid.org/0009-0007-3265-3873
Hongyu Tan *Department of Emergency, Liuzhou Workers' Hospital, the Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.
Dianyang WangDepartment of Emergency, Liuzhou Workers' Hospital, the Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.
Rui SuDepartment of Respiratory and Critical Care Medicine, Liuzhou Workers' Hospital, the Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.
Jiaxiang LiaoDepartment of Emergency, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Hongfei GeDepartment of Critical Care Medicine, Liuzhou Workers' Hospital, the Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.
Wei WangDepartment of Emergency, the First Affiliated Hospital of Guangxi Medical University, Nanning, China. weiwanggx@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis severity is associated with sustained neutrophilia, yet the underlying heterogeneity remains unclear. By integrating single-cell and bulk RNA-seq of septic peripheral blood, we uncovered five neutrophils clusters. FOLR3+neutrophils were the predominant and terminally differentiated subgroup, which displayed hyper-inflammatory signatures and low HLA expression, especially in non-survivors of sepsis. Cell-chat analysis also showed these neutrophils could promote sepsis progression by recruiting platelet via RETN-CAP1 and NAMPT-ITGB1 axes. External validation found that higher FOLR3+neutrophils were associated with 28-day mortality of sepsis. Transcription-factor and pseudotime analyses identified HIF-1A as the key driver of FOLR3+neutrophils specification. In vitro experiments validated that FOLR3 expression and HIF-1A were also found to be higher in sepsis. Over-expression or knockout of HIF-1A in patient and mouse neutrophils confirmed direct control of HIF-1A on secretion of IL-1β, TNF-α, IL-8 and IL-6. In conclusion, FOLR3+neutrophils contribute to sepsis prognosis by exacerbating hyper-inflammation and FOLR3 may serve as a new promising prognostic biomarker for sepsis.

Indexed as

InflammationNeutrophilsSepsisAnimalsHumansHypoxia-Inducible Factor 1, alpha SubunitMaleMiceHIF1A protein, humanHypoxia-Inducible Factor 1, alpha Subunit

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.